Patents by Inventor Karl A. Hansford

Karl A. Hansford has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide antibiotics
    Patent number: 11279733
    Abstract: There is provided a range of novel compounds. These novel compounds may demonstrate abroad spectrum antibacterial and antifungal activity. These compounds may be active against the emerging polymyxin resistant bacteria. These compounds may also be useful when used in conjunction with other pharmaceutically active agents.
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: March 22, 2022
    Assignee: THE UNIVERSITY OF QUEENSLAND
    Inventors: Matthew Cooper, Mark Blaskovich, Alejandra Gallardo-Godoy, Karl Hansford, Alysha Elliott, Craig Muldoon, Bernd Becker
  • PEPTIDE ANTIBIOTICS
    Publication number: 20200361994
    Abstract: There is provided a range of novel compounds. These novel compounds may demonstrate abroad spectrum antibacterial and antifungal activity. These compounds may be active against the emerging polymyxin resistant bacteria. These compounds may also be useful when used in conjunction with other pharmaceutically active agents.
    Type: Application
    Filed: November 2, 2018
    Publication date: November 19, 2020
    Inventors: Matthew COOPER, Mark BKASKOVICH, Alejandra GALLARDEO-GODLY, Karl HANSFORD, Slysha ELLOTT, Craig MULDOON, Bemd BECKER
  • Interleukin-1 receptor antagonists, compositions, and methods of treatment
    Patent number: 8618054
    Abstract: Peptides that are designed to inhibit the biological activity of the IL-1R type 1 receptor and inhibit IL-1R/IL-1RacP related cell signaling and biological activity are disclosed. Compositions comprising IL-1R antagonists of the present invention are useful in the treatment of IL-1 related diseases or conditions such as arthritis, rheumatoid arthritis, osteoarthritis, and inflammatory bowel disease as well as other chronic or acute inflammatory diseases.
    Type: Grant
    Filed: May 5, 2005
    Date of Patent: December 31, 2013
    Assignees: Valorisation-Rechereche Société en Commandite, Valorisation HSJ, Société en Commandite
    Inventors: Sylvain Chemtob, Christiane Quiniou, William D. Lubell, Martin Beauchamp, Karl A. Hansford
  • INTERLEUKIN-1 RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS OF TREATMENT
    Publication number: 20100041609
    Abstract: Peptides that are designed to inhibit the biological activity of the IL-1R type 1 receptor and inhibit IL-1R/IL-1RacP related cell signaling and biological activity are disclosed. Compositions comprising IL-1R antagonists of the present invention are useful in the treatment of IL-1 related diseases or conditions such as arthritis, rheumatoid arthritis, osteoarthritis, and inflammatory bowel disease as well as other chronic or acute inflammatory diseases.
    Type: Application
    Filed: October 15, 2009
    Publication date: February 18, 2010
    Applicant: Valorisation-Recherche, Societe en Commandite
    Inventors: Sylvain Chemtob, Christiane Quiniou, William D. Lubell, Martin Beauchamp, Karl A. Hansford
  • Compounds and inhibitors of phospholipases
    Patent number: 7253194
    Abstract: The present invention relates generally to amino acid derivatives and to methods of making the same. In particular, the invention relates to compounds bearing a stereochemical identity, that is, the same stereochemistry, with the chiral ?-carbon of D-?-amino acids and their use in methods of therapy, including the treatment of inflammatory diseases, and to compositions and enantiomeric mixtures containing them.
    Type: Grant
    Filed: July 24, 2001
    Date of Patent: August 7, 2007
    Assignee: The University of Queensland
    Inventors: Robert C Reid, Christopher I Clark, Karl Hansford, Martin J Stoermer, Ross P McGeary, David P Fairlie, Karl Schafer
  • Interleukin-1 receptor antagonists, compositions, and methods of treatment
    Publication number: 20060094663
    Abstract: Peptides that are designed to inhibit the biological activity of the IL-1R type 1 receptor and inhibit IL-1R/IL-1RacP related cell signaling and biological activity are disclosed. Compositions comprising IL-1R antagonists of the present invention are useful in the treatment of IL-1 related diseases or conditions such as arthritis, rheumatoid arthritis, osteoarthritis, and inflammatory bowel disease as well as other chronic or acute inflammatory diseases.
    Type: Application
    Filed: May 5, 2005
    Publication date: May 4, 2006
    Inventors: Sylvain Chemtob, Christiane Quiniou, William Lubell, Martin Beauchamp, Karl Hansford
  • Compounds and inhibitors of phospholipases
    Publication number: 20040033995
    Abstract: The present invention relates generally to amino acid derivatives and to methods of making the same. In particular, the invention relates to compounds bearing a stereochemical identity, that is, the same stereochemistry, with the chiral &agr;-carbon of D-&agr;-amino acids and their use in methods of therapy, including the treatment of inflammatory diseases, and to compositions and enantiomeric mixtures containing them.
    Type: Application
    Filed: August 25, 2003
    Publication date: February 19, 2004
    Inventors: Robert C. Reid, Christopher I. Clark, Karl Hansford, Martin J. Stoermer, Ross P. McGeary, David P. Fairlie, Karl Schafer